e-learning
resources
Munich 2006
Sunday 03.09.2006
Markers of paediatric airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma
C. M. Robroeks, K. D. van de Kant, Q. Jöbsis, D. van Vliet, H. J. Hendriks, M. F. Wouters, P. P. Rosias, J. G. Damoiseaux, W. W. Wodzig, E. Dompeling (Maastricht, Sittard, Netherlands)
Source:
Annual Congress 2006 - Markers of paediatric airway disease
Session:
Markers of paediatric airway disease
Session type:
Oral Presentation
Number:
786
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. M. Robroeks, K. D. van de Kant, Q. Jöbsis, D. van Vliet, H. J. Hendriks, M. F. Wouters, P. P. Rosias, J. G. Damoiseaux, W. W. Wodzig, E. Dompeling (Maastricht, Sittard, Netherlands). Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma. Eur Respir J 2006; 28: Suppl. 50, 786
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001
Discrepancy of non-invasive inflammatory markers and lung function tests to current level of clinical control in childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice
Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019
Year: 2020
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 327s
Year: 2006
Do exhaled non-invasive inflammatory markers correlate with respiratory symptoms and lung function in a longitudinal study of childhood asthma?
Source: Annual Congress 2011 - Inflammation and genes in childhood asthma
Year: 2011
COPD exacerbation definitions, assessment and diagnosis
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013
Evaluation and management of difficult-to-control asthma
Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside
Year: 2007
Can extended hematological parameters of inflammation predict the severity and outcome of AECOPD?
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
COPD: problems in diagnosis and measurement
Source: Eur Respir J 2003; 21: 4S-12S
Year: 2003
Markers of severity and inflammatory profile during exacerbations of severe asthma.
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017
Which is the most effective inflammatory marker in the diagnosis, severity and treatment follow-up of patients with pneumonia?
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Ultrasound diaphragm activity as a marker of clinical status and prognosis in acute exacerbations of COPD
Source: Virtual Congress 2021 – New insights into the pathophysiology and prognosis of COPD
Year: 2021
Role of biomarkers in the assessment and phenotyping asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
Non-invasive markers of inflammation as a measurement of corticosteroid responsiveness in children with severe asthma (sa)
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Year: 2009
Correlation of clinical, laboratory and functional parameters in stable chronic obstructive pulmonary disease
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label
Source: Eur Respir J, 51 (1) 1701817; 10.1183/13993003.01817-2017
Year: 2018
The role of biomarkers in the management of severe asthma
Source: International Congress 2019 – Severe asthma guidelines: update 2019
Year: 2019
Is pulmonary index score suitable for the evaluation of paediatric acute asthma
Source: Breathe 2011; 7: 372-373
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept